Kwality Pharmaceuticals Q4 Results
- BSE: 539997
- NSE: KPL
- ISIN: INE552U01010
- Sector: Biotechnology & Drugs
BSE
3,549.00
-13.30 (-0.37%)
-13.30 (-0.37%)Volume2.18 K
Updated: Tue 13 Oct, 2026 | 15:28:00
NSE
3,525-40.50 (-1.14%)
-40.50 (-1.14%)Volume25.87 K
Updated: Tue 13 Oct, 2026 | 15:29:47
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Kwality Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 25 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 123.62 | 99.14 | 24.69% | 94.87 | 30.29% |
| Depreciation/ Amortization | 5.26 | 4.82 | 9.17% | 5.09 | 3.51% |
| Operating Income | 33.50 | 24.30 | 37.85% | 20.80 | 61.03% |
| Net Income | 25.30 | 16.01 | 58.04% | 14.49 | 74.62% |
| Other Operating Expenses Total | 17.46 | 20.03 | -12.86% | 16.32 | 7.00% |
| Net Income Before Taxes | 31.67 | 22.35 | 41.72% | 19.07 | 66.02% |
| Total Revenue | 157.11 | 123.44 | 27.28% | 115.68 | 35.82% |
| Selling/ General/ Admin Expenses Total | 14.22 | 14.36 | -0.99% | 12.68 | 12.09% |
| Diluted Normalized EPS | 24.40 | 15.99 | 52.60% | 14.01 | 74.19% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.